顺行入路腔内技术治疗主-髂动脉硬化性闭塞症  

Anterograde endovascular therapy for treating aorta-iliac arteriosclerotic occlusion

作　　者：吴斐[1] 刘俊超[1] 王洛波 丁语[1] 李攀峰[1] 李阳[1] 王兵[1] 

机构地区：[1]郑州大学第五附属医院血管外科,450052

出　　处：《中国实用医刊》2016年第8期1-3,共3页Chinese Journal of Practical Medicine

基　　金：河南省医学科技攻关计划重点项目（201202015）

摘　　要：目的：探讨顺行入路腔内技术在治疗主-髂动脉硬化性闭塞症的应用。方法选取2013年3月至2014年9月顺行入路腔内技术治疗主-髂动脉硬化性闭塞症13例，回顾性分析其病变位置、腔内技术及治疗结果等相关资料。结果13例患者共16处闭塞病变行顺行入路腔内技术，16处闭塞病变完全开通，开通技术成功率为100%，且无严重并发症发生。结论顺行入路腔内治疗主-髂动脉硬化性闭塞症是安全、有效的，可以增加腔内治疗成功率。objective To investigate the application of anterograde endovascular therapy for treating aorta-iliac arteriosclerotic occlusion. Methods Thirteen patients With aorta-iliac arteriosclerotic occlusion treated by anterograde endovascular from March 2013 to September 2014 Were selected. The relative data of lesion locations,endovascular therapy and treatment results Were retrospectively analyzed in all patients. Results There Were 16 occlusions in 13 patients received anterograde endovascular ther-apy. The occlusion Was fully opened in 16 cases,the success rate Was 100% and there Were no severe complications occurred. Conclusions Anterograde endovascular therapy for treating aorta-iliac arterio-sclerotic occlusion is safe and effective,Which can improve the success rate of endovascular therapy.

关 键 词：顺行入路腔内技术 下肢动脉硬化闭塞症 主-髂动脉硬化 

分 类 号：R543.5[医药卫生—心血管疾病]